Aerie: SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Aerie Pharmaceuticals, Inc. (Nasdaq - AERI)

BALA CYNWYD, Pa., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (Nasdaq - AERI) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to be acquired by Alcon (NYSE - ALC). Under the terms of the Agreement, Aerie shareholders will receive, for each Aerie Share, $15.25 in cash. The transaction represents an equity ...Full story available on Benzinga.com